Chrome 2001
.
The Trusted Source InteliHealth Aetna InteliHealth Aetna InteliHealth
Enter Drug Name . Enter Search Term
     
. .
. .
.
Home
Health Commentaries
InteliHealth Dental
Drug Resource Center
Ask the Expert
Interactive Tools

InteliHealth Policies
Site Map
Diseases & Conditions Healthy Lifestyle Your Health Look It Up
Health News Health News
.
Associated Press

Drug Labeling Aimed at Pregnant Women May Change
May 29, 2008

WASHINGTON (AP) -- Doctors may soon get a new way to tell which medications are safe for women to use during pregnancy and when they breastfeed.

Today, prescription drugs carry a code in the fine print of their labels that rank their pregnancy safety: Category A means it's deemed safe; Category X means it's known to harm human fetuses. A drug given the remaining B, C or D codes have varying levels of evidence one way or the other.

That's too confusing, the Food and Drug Administration declared Wednesday. So the agency proposed a change: Strip away the codes. Replace them with clearly marked sections in the drug's label that describe what research shows about fetal risk -- and whether that information comes from studies in people or only in animals -- and other information, such as whether pregnant women need different doses than other patients.

"It's a population that has very, very special needs," FDA Commissioner Andrew von Eschenbach said in announcing the proposal.

There are 6 million pregnancies a year in the United States, and pregnant women take an average of three to five prescription drugs during their pregnancy, the FDA said.

Specialists say there's far too little research done on medication risks during pregnancy and breastfeeding.

But if the new rule takes effect -- it's open for 90 days of public comment before FDA makes a final decision -- the hope is that labels eventually would lay out the pros and cons that are known in ways that help women and their doctors make more rationale decisions, said FDA's Dr. Sandra Kweder, who led the 11-year effort for a change.

For example, a drug today might be labeled Category X when newer research shows the risk for fetal harm is only during the first trimester. Or animal studies might show a drug has the potential to sedate a breastfed baby -- when FDA now knows that so little gets into human breast milk for that risk to be real.

The proposal also says drug labels should include the background risk of birth defects to put warnings in context: If 10 cases of a particular birth defect occur in every 1,000 pregnancies anyway, how many more would occur with use of a certain drug?

Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

.
InteliHealth
. . . .
.
More News
InteliHealth .
.
Top News
General Health
This Week In Health
Addiction
Allergy
Alzheimer's
Asthma
Arthritis
Babies
Breast Cancer
Cancer
Caregiving
Cervical Cancer
Children's Health
Cholesterol
Complementary & Alternative Medicine
Dental / Oral Health
Depression
Diabetes
Ear, Nose And Throat
Eyes
Family Health
Fitness
Headache
Heart Health
HIV / AIDS
Infectious Diseases
Lung Cancer
Medications
Men's Health
Mental Health
Nutrition News
Multiple Sclerosis
Nutrition Guide
Parkinson's
Pregnancy
Prevention
Prostate Cancer
Senior Health
Sexual / Reproductive Health
Sleep
Tobacco Cessation
STDs
Stress Reduction
Stroke
Weight Management
Today In Health History
Women's Health
Workplace Health
.
.
.
.
InteliHealth

   
.
.   HONcode
.
Chrome 2001
Chrome 2001